Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma

Leukemia. 2008 Jun;22(6):1282-4. doi: 10.1038/sj.leu.2405100. Epub 2008 Jan 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Dexamethasone / administration & dosage
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Stem Cell Mobilization*
  • Humans
  • Lenalidomide
  • Multiple Myeloma / therapy*
  • Peripheral Blood Stem Cell Transplantation*
  • Remission Induction
  • Retrospective Studies
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives
  • Treatment Outcome

Substances

  • Granulocyte Colony-Stimulating Factor
  • Thalidomide
  • Dexamethasone
  • Lenalidomide